Background: Differentiated thyroid carcinoma (DTC) during childhood is a rare disease. Its excellent survival rate requires a focus on possible long-term adverse effects. This study aimed to evaluate fertility in female survivors of childhood DTC by assessing various reproductive characteristics combined with anti-Mullerian hormone (AMH) levels (a marker of ovarian reserve).
Methods: Female survivors of childhood DTC, diagnosed at
Conclusions: Female survivors of DTC who received I-131 treatment during childhood do not appear to have major abnormalities in reproductive characteristics nor in predictors of ovarian failure.
- differentiated thyroid carcinoma
- childhood cancer
- adverse effects
- ANTI-MULLERIAN HORMONE
- RADIOACTIVE IODINE ABLATION
- OVARIAN RESERVE
- I-131 THERAPY
- ANTIMULLERIAN HORMONE